<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="97514">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01992757</url>
  </required_header>
  <id_info>
    <org_study_id>818918</org_study_id>
    <nct_id>NCT01992757</nct_id>
  </id_info>
  <brief_title>Thromboelastography-derived Functional Fibrinogen Levels</brief_title>
  <acronym>TEG FF</acronym>
  <official_title>Comparison of Thromboelastography-derived Functional Fibrinogen Levels During and After Cardiopulmonary Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study hopes to determine if thromboelastography-derived functional fibrinogen (TEG-FF)
      levels on cardiopulmary bypass during cardiac surgery can provide information on coagulation
      status sooner, allowing for anticipation of post-bypass bleeding and transfusion
      requirements
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>thromboelastography-derived functional fibrinogen (TEG-FF) level</measure>
    <time_frame>Change from baseline and after cardiac surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>The TEG tracing will quantify a functional fibrinogen level for each patient.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Focus of Study</condition>
  <condition>Coagulation Status of Cardiac Surgery Patient</condition>
  <condition>Reducing Excess Blood Transfusion</condition>
  <arm_group>
    <arm_group_label>Cardiac surgery with cardiopulmary bypass</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The population for this study will be elective cardiac surgical patients who will be
        undergoing elective primary cardiac surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective cardiac surgery patients who are  undergoing primary cardiac surgery

        Exclusion Criteria:

          -  Emergency surgery

          -  Re-operative cardiac surgery

          -  History of hypercoagulable state as defined in medical record

          -  Anticoagulated status at time of surgery

          -  Plasma requirement prior to discontinuation of bypass (alters fibrinogen level)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Prakash A Patel, MD</last_name>
    <phone>2156624000</phone>
    <email>prakash.patel@uphs.upenn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mary S Hammond, BSN RN</last_name>
    <phone>2156623772</phone>
    <email>mary.hammond@uphs.upenn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prakash A Patel, MD</last_name>
      <phone>215-662-4000</phone>
      <email>prakash.patel@uphs.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Mary S Hammond, BSN RN</last_name>
      <phone>215-662-3772</phone>
      <email>mary.hammond@uphs.upenn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Prakash A Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 19, 2013</lastchanged_date>
  <firstreceived_date>November 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>functional fibrinogen assay</keyword>
  <keyword>cardiac surgery</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
